Resveratrol induces DNA damage-mediated cancer cell senescence through the DLC1–DYRK1A–EGFR axis
- 29 December 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 14 (3) , 1484-1497
Abstract
Schematic representation of resveratrol inducing DNA damage-mediated cancer cell senescence through the DLC1–DYRK1A–EGFR axis.Keywords
Funding Information
- National Natural Science Foundation of China (31672377)
This publication has 52 references indexed in Scilit:
- Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene‐induced senescenceEMBO Molecular Medicine, 2013
- Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growthJournal of Clinical Investigation, 2013
- Resveratrol Induces Premature Senescence in Lung Cancer Cells via ROS-Mediated DNA DamagePLOS ONE, 2013
- Senescence-associated secretory phenotype favors the emergence of cancer stem-like cellsCell Death & Disease, 2012
- Four faces of cellular senescenceJournal of Cell Biology, 2011
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer PatientsCancer Research, 2010
- Cellular senescence predicts treatment outcome in metastasised colorectal cancerBritish Journal of Cancer, 2010
- A High-Throughput Method to Identify Novel Senescence-Inducing CompoundsSLAS Discovery, 2009
- DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttlingJournal of Cell Science, 2009
- Living on a break: cellular senescence as a DNA-damage responseNature Reviews Cancer, 2008